For the first time, 'Made in India' drugs launched for rare diseases

The Centre has introduced a game-changing initiative by manufacturing four types of homegrown 'Made in India' drugs for rare diseases. The Central Government has prioritized 13 rare diseases and sickle cell disease. These drugs will bring down costs by up to 100-fold, making them significantly more affordable than imported drugs. The available generic drugs in India are for Tyrosinemia Type, Gaucher's Disease, Wilson's Disease, and Dravet or Lennox Gastaut Syndrome-seizures.